Last reviewed · How we verify

Sapropterin Dihydrochloride and Vitamin C

BioMarin Pharmaceutical · Phase 2 active Small molecule

Sapropterin Dihydrochloride and Vitamin C is a Small molecule drug developed by BioMarin Pharmaceutical. It is currently in Phase 2 development. Also known as: 6R-BH4 and Vitamin C.

At a glance

Generic nameSapropterin Dihydrochloride and Vitamin C
Also known as6R-BH4 and Vitamin C
SponsorBioMarin Pharmaceutical
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sapropterin Dihydrochloride and Vitamin C

What is Sapropterin Dihydrochloride and Vitamin C?

Sapropterin Dihydrochloride and Vitamin C is a Small molecule drug developed by BioMarin Pharmaceutical.

Who makes Sapropterin Dihydrochloride and Vitamin C?

Sapropterin Dihydrochloride and Vitamin C is developed by BioMarin Pharmaceutical (see full BioMarin Pharmaceutical pipeline at /company/biomarin-pharmaceutical).

Is Sapropterin Dihydrochloride and Vitamin C also known as anything else?

Sapropterin Dihydrochloride and Vitamin C is also known as 6R-BH4 and Vitamin C.

What development phase is Sapropterin Dihydrochloride and Vitamin C in?

Sapropterin Dihydrochloride and Vitamin C is in Phase 2.

Related